Sunayana Shah, member of the Royal Pharmaceutical Society (RPS), has been appointed president of the new Industrial Pharmacy Advisory Group (IPAG), which replaces the Industrial Pharmacy Forum from 2021.
IPAG will advise the Company’s national pharmaceutical boards on matters related to industrial pharmacy and pharmaceutical science. It will also support the work of RPS in industry, particularly around the development, implementation and dissemination of professional standards.
Shah has experience in community pharmacy and the pharmaceutical industry. Previously, she worked as Regulatory and Safety Policy Officer at the Association of the British Pharmaceutical Industry (ABPI), where part of her role was to advise UK and EU government officials on issues of international regulatory policy, including Brexit.
“As an advisory group, we hope to provide expert opinions and evidence-based leadership to inform policy decisions and advice from RPS to government and other stakeholders,” Shah said, adding that she was looking forward to working closely with RPS Chief Scientist Gino. Martini and the RPS political teams.
Martini congratulated Shah, adding that the Company is “delighted to have someone who brings a tremendous wealth of experience who can help RPS.
“Having timely access to a network of qualified IPAG experts with diverse backgrounds, ranging from pharmaceutical scientists to pharmacists specializing in the medical, regulatory, safety and manufacturing fields, is a real asset, and j can’t wait to work with her. “